日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Novel Inhibition of Central Carbon Metabolism Pathways by Rac and CDC42 inhibitor MBQ167 and Paclitaxel.

Rac 和 CDC42 抑制剂 MBQ167 和紫杉醇对中心碳代谢途径的新型抑制作用

Cruz-Collazo Ailed M, Katsara Olga, Grafals-Ruiz Nilmary, Colon Gonzalez Jessica, Dorta-Estremera Stephanie, Carlo Victor P, Chorna Nataliya, Schneider Robert J, Dharmawardhane Suranganie

Efficacy and delivery strategies of the dual Rac/Cdc42 inhibitor MBQ-167 in HER2 overexpressing breast cancer

双重 Rac/Cdc42 抑制剂 MBQ-167 对 HER2 过表达乳腺癌的疗效和给药策略

Luis E Velázquez-Vega, Michael Rivera-Robles, Annelis O Sánchez-Álvarez, Pablo E Vivas-Mejía, Miciely Aponte-Reyes, Ailed M Cruz-Collazo, Nilmary Grafals-Ruiz, Stephanie Dorta-Estremera, Eliud Hernández-O'Farrill, Cornelis P Vlaar, Suranganie Dharmawardhane

Characterization of Novel Derivatives of MBQ-167, an inhibitor of the GTP-binding proteins Rac/Cdc42

MBQ-167 新型衍生物(GTP 结合蛋白 Rac/Cdc42 抑制剂)的表征

Julia I Medina, Ailed Cruz-Collazo, Maria Del Mar Maldonado, Tatiana Matos Gascot, Luis D Borrero-Garcia, Mariana Cooke, Marcelo G Kazanietz, Eliud Hernandez O'Farril, Cornelis P Vlaar, Suranganie Dharmawardhane

Efficacy of Rac and Cdc42 Inhibitor MBQ-167 in Triple-negative Breast Cancer

Rac 和 Cdc42 抑制剂 MBQ-167 对三阴性乳腺癌的疗效

Ailed Cruz-Collazo, Jean F Ruiz-Calderon, Hector Picon, Luis D Borrero-Garcia, Irmaris Lopez, Linette Castillo-Pichardo, Maria Del Mar Maldonado, Jorge Duconge, Julia I Medina, Marvin J Bayro, Eliud Hernández-O'Farrill, Cornelis P Vlaar, Suranganie Dharmawardhane

Physiologically-Based Pharmacokinetic/Pharmacodynamic Model of MBQ-167 to Predict Tumor Growth Inhibition in Mice

基于生理的MBQ-167药代动力学/药效学模型预测小鼠肿瘤生长抑制

Reig-López, Javier; Maldonado, María Del Mar; Merino-Sanjuan, Matilde; Cruz-Collazo, Ailed M; Ruiz-Calderón, Jean F; Mangas-Sanjuán, Victor; Dharmawardhane, Suranganie; Duconge, Jorge